Age-associated sarcopenia decreases mobility and is promoted by cell senescence, inflammation, and fibrosis. The mitochondrial enzyme arginase-II (Arg-II) plays a causal role in aging and age-associated diseases. Therefore, we aim to explore the role of Arg-II in age-associated decline of physical activity and skeletal muscle aging in a mouse model. Young (4-6 months) and old (20-24 months) wild-type () mice and mice deficient in () of both sexes are investigated. We demonstrate a decreased physical performance of old mice, which is partially prevented in animals, particularly in males. The improved phenotype of mice in aging is associated with reduced sarcopenia, cellular senescence, inflammation, and fibrosis, whereas age-associated decline of microvascular endothelial cell density, satellite cell numbers, and muscle fiber types in skeletal muscle is prevented in mice. Finally, we demonstrate an increased gene expression level in aging skeletal muscle and found Arg-II protein expression in endothelial cells and fibroblasts, but not in skeletal muscle fibers, macrophages, and satellite cells. Our results suggest that increased Arg-II in non-skeletal muscle cells promotes age-associated sarcopenia, particularly in male mice.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.18632/aging.206173 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!